View in EDS

Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation.

Saved in:
Bibliographic Details
Title: Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation.
Authors: Goode B; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Joseph NM; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Stevers M; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Van Ziffle J; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Onodera C; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Talevich E; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Grenert JP; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Yeh I; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Bastian BC; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA., Phillips JJ; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Garg K; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Rabban JT; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Zaloudek C; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Solomon DA; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, San Francisco, CA, USA.
Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2018 Apr; Vol. 31 (4), pp. 660-673. Date of Electronic Publication: 2017 Nov 17.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0285
DOI:10.1038/modpathol.2017.153